Viewing Study NCT05161533


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-05-19 @ 6:55 PM
Study NCT ID: NCT05161533
Status: WITHDRAWN
Last Update Posted: 2023-10-18
First Post: 2021-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial
Sponsor: University of Washington
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extensive Stage Lung Small Cell Carcinoma View
None Stage IV Lung Cancer AJCC v8 View
None Stage IVA Lung Cancer AJCC v8 View
None Stage IVB Lung Cancer AJCC v8 View
Keywords: